Phase I Study of HRS-3738 in Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma
Clinical trial NCT05363800 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05363800
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-17
- Primary completion
- 2026-12-30
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.